Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: Can biological tests predict the bleeding risk?

Haematologica

Volumn 89, Issue 6, 2004, Pages 704-709

  Giansily Blaizot, Muriel ⁱ   Verdier, Régis ⁱ   Biron Adréani, Christine ⁱ   Schved, Jean François ⁱ   Bertrand, M A ^a   Borg, J Y ^b   LeCam Duchez, V ^b   Briquel, M E ^c   Chambost, H ^d   Pouymayou, K ^d   Dutrillaux, F ^e   Favier, R ^f   Martin Toutain, I ^f   Verdy, E ^f   Gay, V ^g   Goudemand, J ^h   Navarro, R ⁱ   Durin, A ^j   D'Oiron, R ^k   Lambert, T ^k   Pernod, G ^l   Barrot, C ^l   Peynet, J ^m   Bastenaire, B ^m   Sie, P ⁿ   Stieltjes, N ^o   Torchet, M F ^f   De Moerloose, P ^p   more..

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^e DIJON UNIVERSITY HOSPITAL   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g CENTRE HOSPITALIER DE CHAMBÉRY   (France)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ MONTPELLIER UNIVERSITY HOSPITAL   (France)

^j HOSPICES CIVILS DE LYON   (France)

^k CTH Bicêtre   (France)

^l GRENOBLE UNIVERSITY HOSPITAL   (France)

^m CTH Le Chenay   (France)

ⁿ TOULOUSE UNIVERSITY HOSPITAL   (France)

^o CTH Cochin   (France)

^p CHU Geneve   (Switzerland)

more..

Author keywords

Activated FVII; Human recombinant thromboplastin; Inherited FVII deficiency; ROC curve

Indexed keywords

BLOOD CLOTTING FACTOR 7; RECOMBINANT THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; ARTICLE; BLEEDING DISORDER; BLEEDING TENDENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; FEMALE; HEMOSTASIS; HUMAN; MALE; PHENOTYPE; PLASMA; RARE DISEASE; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS, INHERITED; CHILD; CHILD, PRESCHOOL; FACTOR VII; FACTOR VII DEFICIENCY; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK; SEVERITY OF ILLNESS INDEX;

EID: 3042532313     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991;30:10363-70.
2. Broze, GJ Jr, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990;29:7539-46.
3. Triplett DA, Brandt JT, McGann Batard MA, Schaeffer Dixon JL, Fair DS. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood 1985;66:1284-7.
4. Cooper DN, Millar DS, Wacey A, Banner DW, Tuddenham EGD. Inherited factor VII deficiency: molecular genetics and pathophysiology. Thromb Haemost 1997;78:151-60.
5. Peyvandi F, Mannucci PM, Asti D, Abdoullahi M, Di Rocco N, Sharifian R. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency. Haemophilia 1997;3:242-6.
6. Butenas S, Van't Veer C, Mann KG. "Normal" thrombin generation. Blood 1999; 94:2169-78.
7. Giansily-Blaizot M, Aguilar-Martinez P, Biron-Andreani C, Jeanjean P, Igual H, Schved JF. Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency. The Study Group of Factor Seven Deficiency. Eur J Hum Genet 2001;9:105-12.
8. Mac Vey J, Boswell E, Mumford AD, Kemball-Cook G, Tuddenham EGD. Factor VII deficiency and the FVII mutation database. Hum Mutat 2001;17:3-17.
9. Shapiro DE. The interpretation of diagnostic tests. Stat Meth Med Res 1999;8:113-34.
10. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner UU. Measurement of basal levels of factor VIIa in haemophilia A and B patients. Blood 1992;80:25-8.
11. Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 2000;45:23-41.
12. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285-93.
13. Girolami A, Fabris F, Dal Bo Zanon R, Ghiotto G, Burul A. Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 1978;91:387-95.
14. Mariani G, Mazzucconi MG. Factor VII congenital deficiency. Haemostasis 1983;13:169-77.
15. Nordfang O, Bjorn SE, Valentin S, Nielsen LS, Wildgoose P, Beck TC, et al. The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity. Biochemistry 1991;30:10371-6.
16. Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP. Structure and biology of tissue factor pathway inhibitor. Thromb Haemost 2001;86:959-72.
17. Giansily-Blaizot M, Al Dieri R, Schved JF. Thrombin generation measurement in FVII-depleted plasmas compared to inherited FVII deficient-plasmas. Pathophysiol Haemost Thromb 2003;33:36-42.
18. Iacoviello L, Di Castelnuovo A, De Knijff P, D'Orazio A, Amore C, Arboretti R, et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998;338:79-85.
19. De Lange M, Snieder H, Ariëns RAS, Spector TD, Grant PJ. The genetics of haemostasis: a twin study. Lancet 2001; 357:101-5.
20. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003;101:2089-93.
21. Monroe DM, Hoffman M, Oliver JA, Roberts HR. A possible mechanism of action of activated factor VII independent of tissue factor. Blood Coagul Fibrinol 1998;9:S15-S20.
22. Yorke AJ, Mant MJ. Factor VII deficiency and surgery. Is preoperative replacement therapy necessary? JAMA 1977;238:424-5.
23. Giansily-Blaizot M, Biron-Andréani C, Aguilar-Martinez P, de Moerloose P, Briquel ME, Goudemand J, et al. Inherited factor VII deficiency and surgery: clinical data are the best criteria to predict the risk of bleeding. Br J Haematol 2002;117:172-5.